Lebwohl M, Stein Gold L, Gooderham MJ, Papp KA, Ferris LK, Adam DN, Hong HC- ho, Kircik LH, Zirwas M, Burnett P, Higham R. Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults With Chronic Plaque Psoriasis From a 52-Week, Phase 2 Open-Label Safety Trial. J of Skin [Internet]. 2023Jul.17 [cited 2024Sep.20];7(4):s218. Available from: https://dermsquared.com/skin/article/view/2194